Morgan Stanley financials
$192.76−0.45%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $34.47B | $33.15B | $29.99B | $31.19B | $29.35B | $29.13B | $27.16B | $27.37B | $26.48B | $26.27B | $23.83B | $23.42B |
| Gross profit | $21.35B | $20.58B | $17.89B | $18.22B | $16.79B | $17.74B | $16.22B | $15.38B | $15.02B | $15.14B | $12.90B | $13.27B |
| Gross margin | 61.9% | 62.1% | 59.7% | 58.4% | 57.2% | 60.9% | 59.7% | 56.2% | 56.7% | 57.6% | 54.1% | 56.7% |
| Operating income | $7.35B | $7.01B | $5.76B | $6.03B | $4.62B | $5.54B | $4.91B | $4.22B | $4.07B | $4.39B | $2.10B | $3.15B |
| Net income | $5.44B | $5.41B | $4.25B | $4.45B | $3.39B | $4.16B | $3.56B | $3.03B | $2.94B | $3.27B | $1.38B | $2.26B |
| Net margin | 15.8% | 16.3% | 14.2% | 14.3% | 11.6% | 14.3% | 13.1% | 11.1% | 11.1% | 12.4% | 5.8% | 9.7% |
| Diluted EPS | $3.46 | $3.43 | $2.68 | $2.80 | $2.13 | $2.60 | $2.22 | $1.88 | $1.82 | $2.02 | $0.85 | $1.38 |
| EBITDA | $7.35B | $7.01B | $5.76B | $6.03B | $4.62B | $5.54B | $4.91B | $4.22B | $4.07B | $4.39B | $2.10B | $3.15B |
| Operating cash flow | -$2.75B | -$7.10B | -$2.41B | -$3.33B | $11.83B | -$23.98B | $11.80B | -$17.32B | $10.29B | -$3.40B | -$17.75B | $3.75B |
| Free cash flow | -$3.57B | -$7.85B | -$3.12B | -$4.04B | $11.07B | -$24.69B | $10.92B | -$18.24B | $9.43B | -$4.22B | -$18.68B | $2.83B |
| Diluted shares | 1,569.0M | 1,576.0M | 1,585.0M | 1,590.0M | 1,593.0M | 1,600.0M | 1,608.0M | 1,609.0M | 1,611.0M | 1,616.0M | 1,627.0M | 1,643.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $160.13B | $133.53B | $111.69B | $103.73B | $109.13B | $90.74B |
| Short-term investments | $1.01T | $970.02B | $863.98B | $828.20B | $835.81B | $817.80B |
| Total debt | $443.11B | $391.16B | $387.85B | $347.62B | $347.99B | $321.99B |
| Total assets | $1.68T | $1.58T | $1.42T | $1.36T | $1.35T | $1.30T |
| Total liabilities | $1.56T | $1.47T | $1.31T | $1.25T | $1.24T | $1.19T |
| Shareholders' equity | $117.44B | $115.38B | $112.65B | $111.05B | $109.27B | $107.85B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology